Neuroscience
Parkinson's Disease
100%
Transcription Factor Nrf2
100%
Antioxidant Responsive Element
100%
Triterpenoid
66%
Tetrahydropyridine
33%
Neurodegeneration
33%
Antioxidant
25%
Synuclein
25%
Neuroprotective Agent
25%
Dopaminergic
25%
Dopaminergic Neuron
16%
Cell Signaling
16%
Neurotoxin
8%
Bardoxolone
8%
Anti-Inflammatory
8%
Neuroprotection
8%
Neurodegenerative Disorder
8%
Transgene
8%
Leucine Zipper
8%
Substantia nigra
8%
Stereotypic Movement Disorder
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antioxidant
100%
Transcription Factor Nrf2
100%
Parkinson's Disease
100%
Triterpenoid
61%
Dopamine Receptor Stimulating Agent
38%
Nerve Degeneration
30%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
30%
Neuroprotective Agent
23%
Synuclein
23%
Inflammation
15%
Mouse Model
15%
Nervous System Inflammation
7%
Anti-Inflammatory Drug
7%
Combination Therapy
7%
Degenerative Disease
7%
Cytoprotective Agent
7%
Neurotoxin
7%
Motor Dysfunction
7%
Bardoxolone
7%
Neuroprotection
7%
Knockout Mouse
7%
Bioavailability
7%
Leucine Zipper Protein
7%
Keyphrases
Antioxidant Response Element
50%
Therapeutic Target
50%
Parkinson's Disease
50%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
50%
Triterpenoids
25%
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
20%
Parkinson's Disease Model
15%
Dopaminergic Neurodegeneration
15%
Alpha-synuclein (α-syn)
15%
Natural Triterpenoids
15%
Signaling Pathway
10%
Mouse Model
10%
Nrf2 Knockout Mice
10%
Oxidative Damage
10%
Relative Efficacy
10%
Neuroprotective
10%
Neurodegenerative Diseases
5%
Neurotherapeutics
5%
Leucine Zipper
5%
Therapeutic Efficacy
5%
Potential Therapeutics
5%
Cytoprotective Genes
5%
Neurodegeneration
5%
Gene number
5%
Inflammatory Genes
5%
Dopaminergic Neurons
5%
Specific Intent
5%
Transcription Factor Nrf2
5%
Disease Pathogenesis
5%
Mitochondrial Dysfunction
5%
Neuroprotective Effect
5%
Therapeutic Candidates
5%
Therapeutic Intervention
5%
Neuroinflammation
5%
Potential Drugs
5%
Neurodegenerative Movement Disorder
5%
Regulatory Factors
5%
Public Health
5%
Parkinsonian
5%
A53T
5%
Inflammation
5%
Nigral Dopaminergic Neuron
5%
Antioxidant System
5%
Substantia Nigra
5%
Mechanism of Action
5%
Mode of Action
5%
Neurotoxin
5%
Cyano
5%
Antioxidant Genes
5%
Anti-inflammatory Molecules
5%
Drug Candidates
5%
Dopamine
5%
United States
5%
Oral Administration
5%
Rodent Models
5%
Neuroprotection
5%
Enhanced Bioavailability
5%
Antioxidant
5%
Oxidative Inflammation
5%